eHealth, Inc. short interest in 2025
In 2025, eHealth, Inc.'s disclosed short interest ran from 0.70% of shares outstanding on 15 Jan 2025 to 2.35% on 31 Dec 2025, a change of +1.65 percentage points. The year's high was 3.06% on 30 Sep 2025 and its low 0.62% on 30 May 2025, averaging 1.71% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.62 days on 30 Sep 2025. Full history: eHealth, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 0.70% (15 Jan 2025)
- End of year
- 2.35% (31 Dec 2025)
- Change
- +1.65 pp
- High
- 3.06% (30 Sep 2025)
- Low
- 0.62% (30 May 2025)
- Average
- 1.71%
- Highest days to cover
- 3.62 (30 Sep 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 0.70% | 1.00 | |
| 31 Jan 2025 | 0.72% | 1.00 | |
| 14 Feb 2025 | 0.75% | 1.00 | |
| 28 Feb 2025 | 0.78% | 1.00 | results (8-K), 10-K filed |
| 14 Mar 2025 | 0.91% | 1.00 | |
| 31 Mar 2025 | 0.90% | 1.37 | |
| 15 Apr 2025 | 1.22% | 1.87 | |
| 30 Apr 2025 | 0.93% | 1.94 | |
| 15 May 2025 | 0.76% | 1.00 | 10-Q filed, results (8-K) |
| 30 May 2025 | 0.62% | 1.00 | |
| 13 Jun 2025 | 1.15% | 1.47 | |
| 15 Aug 2025 | 2.67% | 1.00 | results (8-K), 10-Q filed |
| 29 Aug 2025 | 2.68% | 3.18 | |
| 15 Sep 2025 | 2.69% | 2.87 | |
| 30 Sep 2025 | 3.06% | 3.62 | |
| 15 Oct 2025 | 2.34% | 1.79 | |
| 31 Oct 2025 | 2.88% | 2.09 | |
| 14 Nov 2025 | 2.61% | 2.19 | results (8-K), 10-Q filed |
| 28 Nov 2025 | 2.66% | 2.96 | |
| 15 Dec 2025 | 2.53% | 2.99 | |
| 31 Dec 2025 | 2.35% | 1.42 |
See also: eHealth, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.